Back to search
Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III) trials you may qualify forThis study compares how effective is the molecular screening (a blood test) using Pap smear as reference, that is, a comparison of these tests abilities to dete…
This is a non-randomized, open label study to assess the reduction of Human Papillomavirus (HPV) infectivity and transmission in women positive for HPV16 and/or…
The primary goal of this phase I open label study is to determine the safety and tolerability of pNGVL4aCRTE6E7L2 DNA vaccine, as administered by intramuscular…
This is a randomized, open-label trial, to assess whether a single dose of HPV nonavalent vaccine, administered to HIV uninfected, unvaccinated women with high…
This trial studies the prevalence of anal dysplasia and anal cancer in patients with cervical, vaginal, and vulvar dysplasia and cancer. Studying samples collec…